<DOC>
	<DOCNO>NCT00738686</DOCNO>
	<brief_summary>The aim AUTAX study investigate frequency MACCE patient multivessel disease multiple Taxus stent implantation `` real world '' stenting 30 day , 6 12 month 2 year follow-up . Because multivessel stenting use DES limit due economic consideration , secondary aim enhance experience multivessel stenting drug-eluting stent order improve short- long-term outcome patient severe multiple coronary artery stenosis . The objective study : 1 . To determine frequency MACCE 30-day , 6 12-month 2 year clinical follow-up multivessel intervention drug-eluting stent prospective patient cohort.. 2 . To determine rate in-stent restenosis , target lesion target vessel revascularization ( angiographic measure ) 6 month patient multiple DESs multiple lesion . 3 . To investigate clinical angiographic outcome implantation multiple DESs subgroup patient accompany disease ( diabetes mellitus , renal insufficiency ) know high restenosis late complication rate . 4 . To evaluate potential cost burden attempt strategy complete revascularization multiple DES patient multivessel disease .</brief_summary>
	<brief_title>Austrian Multivessel Taxus-Stent Registry</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>symptomatic coronary multivessel disease possible percutaneous complete coronary revascularization age &gt; 18 year significant coronary lesion least 2 vessel acute myocardial infarction within 48 hour contraindication clopidogrel , aspirin , heparin taxol pregnancy lack protection pregnancy breastfeed study hemorrhagic diathesis platelet count &lt; 100.000/ml3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>drug-eluting stent</keyword>
	<keyword>percutaneous coronary intervention</keyword>
	<keyword>major adverse cardiac event</keyword>
	<keyword>in-stent restenosis</keyword>
	<keyword>stent thrombosis</keyword>
</DOC>